Document is current
Any future updates will be listed below
-
Authors
Levine, Ross L. https://orcid.org/0000-0002-7884-1905
Rathmell, W. Kimryn
- License Information
-
More Information
Article History
First Online: 5 June 2020
Competing interests
: R.L.L. is on the supervisory board of Qiagen and is a scientific advisor to Loxo/Lilly, Zentalis, Imago, Mana Therapeutics, Auron, Ajax, Syndax, C4 Therapeutics and Isoplexis. He has consulted for Incyte, Syndax, Celgene and Roche. He receives research support from Prelude Therapeutics and has reviewed grants for Celgene and Gilead. W.K.R. receives research support from Incyte and has clinical trial support from Merck, Genentech, BMS, Pfizer, Novartis, Incyte and Calithera.
Free to read: This content has been made available to all.
